The following informations are relevant to the Supply Situation of Myozyme. The documents below represent guidance to physicians...
Author: IPA
Archive
January 14, 2009
The following documents are relevant to the Supply Situation. The documents below represent guidance to physicians and patients...
Author: IPA
Archive
January 14, 2009
The US Food and Drug Administration (FDA) has informed Genzyme that the FDA plans an accelerated approval for...
Author: Genzyme
Archive
November 16, 2008
New PDUFA Date Set for February 28, 2009 Genzyme Corporation (Nasdaq: GENZ) today announced that the FDA plans...
Author: Genzyme
Archive
November 16, 2008
Click here to view. (PDF, 12 kB)
Author: Genzyme
Archive
November 9, 2008
CRANBURY, N.J., June 3, 2008—Amicus Therapeutics, a biopharmaceutical company developing small molecule, orally-administered pharmacological chaperones for the treatment...
Author: Amicus
Archive
June 2, 2008
This article provides a link to the pdf version of Genzyme’s press release regarding Myozyme manufacturing.  CAMBRIDGE, MA...
Author: Genzyme
Archive
April 21, 2008
Download the April 2008 Pompe Program Update (PDF, 24 kB)
Author: Genzyme
Archive
April 20, 2008
This update contains important information concerning the supply of Myozyme in the United States.  Download the January 2008...
Author: Genzyme
Archive
January 14, 2008
CAMBRIDGE, Mass. – Genzyme Corp. (Nasdaq: GENZ) announced today that its Late Onset Treatment Study (LOTS) of Myozyme®...
Author: Genzyme
Archive
December 12, 2007
1 31 32 33 34 35 38